Prostate Cancer
Interactive training workshop to improve prostate mpMRI knowledge: results from the ESOR Nicholas Gourtsoyiannis teaching fellowship.
January 26, 2024
Functional Outcomes After Localized Prostate Cancer Treatment.
January 26, 2024
Impact of PSMA PET on Prostate Cancer Management.
January 26, 2024
Meta-Analysis Evaluating the Impact of Site of Metastasis on Overall Survival in Men With Castration-Resistant Prostate Cancer.
January 26, 2024
The association of body mass index with tumor aggression among men undergoing radical prostatectomy.
January 25, 2024
Effect of Concomitant Medications on Treatment Response and Survival in De Novo Metastatic Prostate Cancer: Secondary Analysis of the LATITUDE Study.
January 25, 2024
Physician Perception of Grade Group 1 Prostate Cancer.
January 25, 2024
First-in-human study of PSMA-targeting agent, [18F]AlF-P16-093: dosimetry and initial evaluation in prostate cancer patients.
January 24, 2024
UCHL1 is a potential molecular indicator and therapeutic target for neuroendocrine carcinomas.
January 24, 2024
Divergent immune microenvironments in two tumor nodules from a patient with mismatch repair-deficient prostate cancer.
January 24, 2024
Preparation, Optimization, and In-Vitro Evaluation of Brusatol- and Docetaxel-Loaded Nanoparticles for the Treatment of Prostate Cancer.
January 24, 2024